Quick Takeaways
- Roshawn A. Blunt has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Roshawn A. Blunt and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KRON | Kronos Bio, Inc. | Director | 20 Jun 2025 | |||
| OKUR | Reneo Pharmaceuticals, Inc. | Director | 06 Jun 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|